Select Page
Contact Us
Contact Us

Catalent Partnering with Over 30 Customers on COVID-Related Vaccines and Therapies

Featured in ABC News Nightline segment on manufacturing contributions to the COVID-19 fight
Learn More

CATALENT HAS ACQUIRED MASTHERCELL

Enhancing capabilities in cell and gene therapy development and manufacturing to create a comprehensive solution for advanced biotherapeutics
Learn More
Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives.
Learn More

CATALENT ACQUIRES PREMIER EUROPEAN SITE FROM
BRISTOL-MYERS SQUIBB

Enhancing Biologics and Oral dose capabilities and capacity for product launch and commercial packaging
Learn More

Your Expert Partner in Gene Therapy

Industry-leading expertise in adeno-associated viral vector (AAV) development and manufacturing
Learn More

Introducing OneBio™ Suite

Accelerating timelines through integrated biologics development, manufacturing & supply
Learn More

Catalent Partnering with Over 30 Customers on COVID-Related Vaccines and Therapies

Featured in ABC News Nightline segment on manufacturing contributions to the COVID-19 fight
Learn More

CATALENT HAS ACQUIRED MASTHERCELL

Enhancing capabilities in cell and gene therapy development and manufacturing to create a comprehensive solution for advanced biotherapeutics.

Learn More
Catalent is the #1 partner in helping pharmaceutical, biotech and consumer health innovators develop, deliver and supply superior products that improve people’s lives.
Learn More

CATALENT ACQUIRES PREMIER EUROPEAN SITE FROM BRISTOL-MYERS SQUIBB

Enhancing Biologics and Oral dose capabilities and capacity for product launch and commercial packaging
Learn More

YOUR EXPERT PARTNER IN GENE THERAPY

Industry-leading expertise in adeno-associated viral vector (AAV) development and manufacturing

Learn More

INTRODUCING ONEBIO™ SUITE

Accelerating timelines through integrated biologics development, manufacturing & supply.

Learn More

How can we work together

Oral
Biologics
Clinical Supply
Consumer

Latest News

Catalent Signs Development Agreement with Ennaid Therapeutics on its COVID-19 Lead Program

CATALENT RESPONDS TO THE GLOBAL COVID-19 OUTBREAK

We are taking decisive action to minimize the impact of the COVID-19 pandemic on our employees, partners, customers, and their patients.

LEARN MORE

Gene Therapy

With experience across more than 60 gene therapy programs and leading expertise in AAV Vectors, Paragon Gene Therapy will provide you with full life cycle support of your life-saving therapeutic.

FLEXDIRECT™ DIRECT-TO-PATIENT SERVICES

With the growth in semi and fully remote clinical studies, our flexible direct-to-patient offerings enable clinical supplies to be sent directly to patients’, reducing or eliminating the need for in person clinical site visits.

Global Network

With our broad range of experience and deep expertise, we have the talent and unique technologies to transform your concepts into excellent results. This is backed by our global reach, with facilities located worldwide enabling us to tailor a solution to fit your needs.

SEE ALL LOCATIONS

Join Our Team

Catalent is growing & hiring! Join the global drug development and delivery leader that puts “Patient First” at the center of our work every day. Learn more about careers at Catalent.

VIEW ALL NEWS
VIEW ALL EVENTS

EXPERT CONTENT

Drug Manufacturing in a Time of Coronavirus

Why do new Therapies Succeed or fail in the Marketplace?

Elemental Impurities – Guidelines, Testing and Assessments

Softgel Technology for Fast-Tracked Development Programs

Flexible Manufacturing Strategies: What’s Best for your Product?

VIEW ALL ARTICLES